期刊文献+

静脉补铁治疗在慢性心力衰竭合并铁缺乏患者中的应用 被引量:4

Application of intravenous iron therapy in patients with chronic heart failure complicated with iron deficiency
原文传递
导出
摘要 由于各种原因,特别是铁调素的影响,慢性心力衰竭患者常合并铁缺乏,伴或不伴贫血。机体缺铁造成能量代谢异常,会加重心力衰竭的临床表现,造成恶性循环。补铁治疗可以纠正心力衰竭患者体内的缺铁状态。口服补铁吸收及利用度较低,静脉补铁速度快。多项研究表明,对于射血分数减低的心力衰竭患者,静脉补铁治疗可以改善心力衰竭临床症状、增加运动耐力以及提升生活质量,还有可能降低心力衰竭住院率及死亡风险。本文对静脉补铁治疗的特点以及静脉补铁治疗在慢性心力衰竭合并铁缺乏患者中的应用及研究进展进行综述。 Due to various reasons,especially the influence of hepcidin,patients with chronic heart failure often had iron deficiency,with or without anemia.Iron deficiency bring in abnormal energy metabolism and heart failure deterioration,that resulted in a vicious cycle.Iron supplementation can correct iron deficiency in patients with heart failure.The absorption and utilization of oral iron was unsatisfactory,while the intravenous iron supplementation was fast.Several studies had shown that intravenous iron therapy in heart failure patients can relieve clinical symptoms of heart failure,increase exercise endurance and improve the life quality,and may also reduce the rate of hospitalization and death risk of heart failure.The clinical application and development of intravenous iron therapy in heart failure patients with iron deficiency was summarized in this paper.
作者 许永健 田庄 XU Yong-jian;TIAN Zhuang(Department of Internal Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Cardiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)
出处 《临床药物治疗杂志》 2021年第8期1-6,共6页 Clinical Medication Journal
基金 北京市自然科学基金(7192155)。
关键词 慢性心力衰竭 铁缺乏 铁调素 chronic heart failure iron deficiency hepcidin
  • 相关文献

参考文献1

二级参考文献26

共引文献796

同被引文献23

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部